Karas Kevin R 4
4 · NATIONAL RESEARCH CORP · Filed Jun 9, 2020
Insider Transaction Report
Form 4
Karas Kevin R
SVP Finance, CFO, Treas & Secy
Transactions
- Sale
Common Stock
[F1]2020-06-05$57.28/sh−6,858$392,847→ 10,718 total - Sale
Common Stock
[F2]2020-06-05$58.62/sh−6,718$393,828→ 4,000 total - Exercise/Conversion
Common Stock
2020-06-05$14.50/sh+20,088$291,276→ 24,088 total - Tax Payment
Common Stock
2020-06-05$57.22/sh−9,704$555,263→ 14,384 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
[F3]2020-06-05−20,088→ 0 totalExercise: $14.50Exp: 2023-01-07→ Common Stock (20,088 underlying)
Footnotes (3)
- [F1]The price in Column 4 is a weighted average price. The prices actually received ranged from $57.00 to $57.80, inclusive. The reporting person has provided the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges set forth in footnotes (1) and (2) to this Form 4.
- [F2]The price in Column 4 is a weighted average price. The prices actually received ranged from $58.00 to $58.93, inclusive.
- [F3]This option became fully exercisable on January 7, 2018.
Signature
/s/ Kevin R. Karas, by Christopher Kortum, attorney-in-fact, pursuant to a POA previously filed with the SEC|2020-06-09